DCOY

Decoy Therapeutics Inc

May 20 • 04:00PM ET

5.56

+0.26 4.91 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BCDA PALI SHPH BIVI TNXP

| Held by: MEDX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-124.04	Insider Own	5.56%	Shs Outstand	0.53M	Perf Week	15.35%
Market Cap	2.96M	Forward P/E	-	EPS next Y	-	Insider Trans	20.21%	Shs Float	0.50M	Perf Month	-4.79%
Enterprise Value	-4.86M	PEG	-	EPS next Q	-	Inst Own	0.30%	Short Float	2.26%	Perf Quarter	-41.97%
Income	-13.03M	P/S	-	EPS this Y	-	Inst Trans	0.60%	Short Ratio	0.50	Perf Half Y	-49.59%
Sales	0.00M	P/B	0.76	EPS next Y	-	ROA	-242.20%	Short Interest	0.01M	Perf YTD	-28.59%
Book/sh	7.29	P/C	0.38	EPS next 5Y	-	ROE	-661.73%	52W High	415.80 -98.66%	Perf Year	-96.07%
Cash/sh	14.69	P/FCF	-	EPS past 3/5Y	81.80% 62.32%	ROIC	-336.14%	52W Low	4.32 28.70%	Perf 3Y	-99.73%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.86% 8.74%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	86.68%	Oper. Margin	-	ATR (14)	0.52	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	1.84	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.76	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.84	EPS Q/Q	97.74%	SMA20	2.61%	Beta	0.38	Target Price	30.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-9.79%	Rel Volume	0.16	Prev Close	5.30
Employees	11	LT Debt/Eq	0.00	Earnings	Mar 30	SMA200	-78.11%	Avg Volume	22.77K	Price	5.56
IPO	Jan 29, 2015	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	3,754	Change	4.91%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)